Biomatics Capital Partners
QuietFiled to raiseSeattle, WABiotechnology, HealthcareLast fund filed 2018
2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Biomatics Capital Partners IIFiled to raise in 2018, with no closing reported yet. | 2018 | $300M | $0 | 0 |
| Biomatics Capital Partners | April 2016 | $200M | $200M | 38 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
2 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Boris Nikolic | Quiet | Biotech & pharma, Cybersecurity, Medical devices | 4 |
Classified sectors of Biomatics Capital Partners’s own portfolio companies, based on 7 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Biomatics Capital Partners’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| 270 Healthcare Growth | 1 | Compass Therapeutics |
| Aditum Bio | 1 | eGenesis |
| ARCH Venture Partners | 1 | eGenesis |
| Atlas Venture | 1 |
| 0 |
| Julie Sunderland | Quiet | Biotech & pharma, Healthcare services, Medical devices | 5 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| Editas Medicine |
| Bain Capital Life Sciences | 1 | Editas Medicine |
| Borealis | 1 | Compass Therapeutics |
| Caduceus Capital | 1 | Compass Therapeutics |
| Curie Bio | 1 | Editas Medicine |
| DCVC | 1 | Blue Talon Data Systems |
| Dimension Capital | 1 | Variant Bio |
| Greatpoint Ventures Innovation | 1 | Guide Therapeutics |
| Kendall Capital Partners | 1 | eGenesis |
| Lux Capital | 1 | Variant Bio |
| NaviMed Partners | 1 | Aledade |
| Orbimed Genesis | 1 | Compass Therapeutics |
A shared board seat: a company where filings name a Biomatics Capital Partners partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.